Medtronic Plc

NYSE:MDT  
127.70
+2.90 (+2.32%)
5:10:09 PM EDT: $122.30 -5.40 (-4.23%)
Products

U.S. FDA Says Medtronic Recalls Pipeline Flex Embolization Devices

Published: 09/20/2021 16:13 GMT
Medtronic Plc (MDT) - FDA Says Medtronic Recalls Pipeline Flex Embolization Devices for Risk of Delivery System Fractures During Placement, Retrieval, Or Movement of Device.
FDA Says Identified Medtronic's Recall of Pipeline Flex Embolization Devices As a Class I Recall.
FDA Says There Have Been 10 Serious Injuries, and Two Deaths Related to Recall of Pipeline Flex Embolization Devices.
FDA Says There Have Been 59 Reported Device Malfunctions Related to Recall of Pipeline Flex Embolization Devices.
Further Company Coverage: Mdtn ((reuters.
Briefs@thomsonreuters.
Com;)).